Subscribe to Email Updates

    Ophthalmology Tech Summit 2022 facilitates connections to drive innovation

    Octane’s annual Ophthalmology Tech Summit is back in Newport Beach at the Balboa Bay Resort on June 16-17. Southern California is the worldwide leader in ophthalmic innovation and Octane’s event is a must-attend gathering for industry, physicians, industry partners, investors and entrepreneurs. 
     
    Octane will convene major industry leaders and startups, as well as some of the most-influential leaders and industry advocates in-person and virtually, giving a global audience access to a powerhouse event. The Summit’s premiere sponsors Aerie Pharmaceuticals, Alcon, Allergan an AbbVie Company, Johnson & Johnson Vision, STAAR Surgical, Visionary Venture Fund, and many more
     
    “This year we’ve added a physician and entrepreneur reception, creating a unique opportunity for physicians to meet these innovative entrepreneurs and determine if there is a mutually beneficial fit and interest to get more involved, such as becoming a board member or advisor. In addition to hosting premier content, we believe in the power of making connections within our ecosystem to drive impact said Bill Carpou, CEO of Octane.
     
    Octane is uniquely qualified to provide this opportunity as they continue to bridge the relationships they have with physicians and the companies that have used their LaunchPad SBDC Accelerator. The Partnership Pursuit reception will be held the evening before the Summit begins on Thursday, June 16 and is invite only.
     
    A highlight of Ophthalmology Tech Summit will be an interview of David Endicott, CEO of Alcon, conducted by Jim Mazzo, Executive Chairman, Neurotech. Other featured panels include Current State and Future Outlook of the Ophthalmic Landscape and Innovation Leadership Panels in both Device and Pharma
     
    The conference will conclude with Octane’s annual Company Presentations. Five companies will present including LaunchPad SBDC Accelerator program graduates ForwardVue Pharma, Inc., IOPtic, Inc., Kato Pharmaceuticals, and Octane Capital & Growth portfolio companies SalutarisMD and Smartlens. These companies represent the next generation of ophthalmic solutions with innovations in pharmaceuticals, glaucoma, retinal disease treatment and device. 
     
    Octane’s Ophthalmology Tech Summit facilitates the connections between leading physicians, industry, investors, and entrepreneurs that help drive innovation, all in a beautiful location on the harbor. 
     
    “We are thrilled to have Ophthalmology Tech Summit 2022 in person as well as allow people to join virtually to access the content and networking opportunities through our event app and platform” shared Cara Parchment, Senior Signature Event Manager at Octane.
     
    Session recordings will be available for registered guests for a limited time following the Summit.
     
    For the full agenda and registration information visit: https://octaneoc.org/ophthalmology-tech-summit/  
     

    Ophthalmology Tech Summit 2022 | June 16-17

    Balboa Bay Resort 1221 West Coast Hwy, Newport Beach, CA 92663

    Related Categories

    Events Ophthalmology Innovation

    Let Us Know What You Thought about this Post.

    Put your Comment Below.

    You may also like:

    Events Ophthalmology Innovation

    The Success of Ophthalmology Tech Summit 2022

    With over 700 registered attendees at the conference, either at beautiful Balboa Bay Resort or tuning in virtually, Opht...

    Events Tech

    Future Focus at Tech Innovation Forum 2022

    Tech Innovation Forum was a huge success! With over 25 presenting companies, two days of exciting content, and great net...

    Events Med Tech

    Politically Incorrect Diversity in Clinical Trials

    Read the full article on appliedclinicialtrialsonline.com